OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ABBV

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

ABBVIE (ABBV) Earnings Date & Reports

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ABBV is expected to report earnings to rise 9.76% to $3.26 per share on October 24

Q3'25

Est.

$3.26

Q2'25

Beat

by $0.01

Q1'25

Beat

by $0.07

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.08

The last earnings report on July 31 showed earnings per share of $2.97, beating the estimate of $2.96. With 1.40M shares outstanding, the current market capitalization sits at 322.43B.

View a ticker or compare two or three

Compare

ABBV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ABBV
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABBV showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

1 North Waukegan Road

Phone

+1 847 932-7900

Employees

50000

Web

http://www.abbvieinvestor.com